Press release
CD Bioparticles Announces Comprehensive Assay Portfolio for mRNA-LNP Vaccine Development
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is pleased to announce a suite of comprehensive mRNA-LNP Vaccine [https://www.cd-bioparticles.net/services/bioparticles-analysiscand-characterization/mrna-lnp-vaccine-laboratory-process-development-assay] Laboratory Process Development Assays. This latest addition to CD Bioparticles' extensive service portfolio is specifically designed for the rapid and efficient development of mRNA-LNP vaccines.
The mRNA molecule is well known to the public through COVID-19 and the mRNA vaccine made from it is characterized by rapid blocking of pathogen mutation response, simple production process and scale-up. Detection and validation methods are the basis for quality control of mRNA LNP vaccines. Therefore, R&D companies should establish detection methods for the characteristics of mRNA, liposomes and formulations, as well as related impurities and other key quality attributes of mRNA vaccines to ensure the safety and efficacy of mRNA-LNP vaccines.
CD Bioparticles now offers a comprehensive portfolio of laboratory assays designed to support every stage of mRNA-LNP vaccine development. These assays provide researchers with the tools they need to optimize their vaccine formulations and ensure their safety and efficacy, accelerating the path to clinical trials and commercialization. In addition, CD Bioparticles' team of scientific experts is available to work with researchers to develop custom assays to meet their specific needs.
CD Bioparticles mRNA-LNP vaccine assay portfolio encompasses a variety of methodologies, including Cellular Uptake Studies,mRNA Transfection Efficiency Study, In Vivo Biodistribution, Histopathological Studies, Biochemical Indicators Testing, and Detection of Antigen-Specific T Cells. By leveraging CD Bioparticles' expertise in analysis and characterization, researchers can gain deeper insights into the properties and performance of their vaccines, enabling them to make informed decisions during the development process.
For example, in the mRNA Transfection Efficiency Study, DC2.4 cells are selected as the model cells for the infection experiment. After infecting the cells with GFP-mRNA-LNP, the intracellular GFP signal will be observed by fluorescence microscopy. CD Bioparticles can assist customers with immunostaining studies that not only examine the efficiency of mRNA transmission, but also help to identify the specific cell types that are transfected into a specific type of organ.
CD Bioparticles also offers In Vivo Biodistribution services. To visualize the distribution of LNP in an organism, the professionals use fluorescent dyes (e.g., DiD and DiO) and luciferase for labeling. Typically, luciferase mRNA (Luc-mRNA) is used as a model mRNA to follow the distribution of the expressed protein in vivo. After intravenous injection of Luc-mRNA-LNP, heart, liver, spleen, lung, kidney and lymph node tissues are isolated. The tissues will be visualized using the IVIS Spectral Live Image System. This will facilitate visualization studies of organ distribution and duration of protein activity production.
CD Bioparticles' new mRNA-LNP assays are available to researchers and vaccine developers worldwide. The company is committed to providing cutting-edge technologies and services that support the advancement of biotechnology and improve human health. For more information about the services, please visit https://www.cd-bioparticles.net/services/bioparticles-analysiscand-characterization/mrna-lnp-vaccine-laboratory-process-development-assay.
About CD Bioparticles
CD Bioparticles is an established drug delivery company that provides customized solutions for developing and manufacturing novel biocompatible drug delivery systems. It specializes in various formulation and drug delivery technologies, from conventional liposomes and PEGylated liposomes to polymer microspheres and nanoparticles for drug delivery. The company also provides contract research services for drug delivery formulation, formulation feasibility study, process development and scale-up, as well as analytical and non-clinical research services.
Media Contact
Company Name: CD Bioparticles
Contact Person: Richard J. Gray
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cd-bioparticles-announces-comprehensive-assay-portfolio-for-mrnalnp-vaccine-development]
State: New York
Country: United States
Website: https://www.cd-bioparticles.net/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CD Bioparticles Announces Comprehensive Assay Portfolio for mRNA-LNP Vaccine Development here
News-ID: 3506683 • Views: …
More Releases from ABNewswire
Automotive Fuel Tank Market to Reach USD 25.48 Billion by 2030; Driven by Lightw …
Mordor Intelligence has published a new report on the automotive fuel tank market offering a comprehensive analysis of trends, growth drivers, and future projections.
Introduction
According to a recent report by Mordor Intelligence, The automotive fuel tank market [https://www.mordorintelligence.com/industry-reports/automotive-fuel-tank-market?utm_source=abnewswire] reached USD 20.15 billion in 2025 and is forecast to climb to USD 25.48 billion by 2030, reflecting a 4.80% CAGR. This growth is anchored in a mix of traditional internal-combustion-engine (ICE) demand,…
What Does Dry Needling Austin Actually Do? Austin Clinic Reports Growing Demand …
Austin Clinic Deep Relief reports increased demand for dry needling as patients seek alternatives for chronic muscle pain. The technique targets trigger points to reduce discomfort and improve movement through natural healing responses.
Demand for dry needling Austin treatments has surged as residents seek alternatives to medication for chronic muscle pain, according to reports from local healthcare providers. Deep Relief, a therapeutic clinic located in Oak Hill, has observed increased interest…
What Is a Reefer in Refrigeration? Thermo King Reefer Repair Demand Grows in Dal …
The Dallas logistics sector relies on reefer units-mobile refrigeration systems for temperature-sensitive cargo. Growing demand for qualified repair services reflects the region's expanding role in cold chain distribution networks.
The transport refrigeration sector in Dallas continues to expand as more businesses recognize the value of temperature-controlled cargo systems. Industry professionals often search for What Is a Reefer in Refrigeration? [https://texasreefersolutions.com/f/what-is-a-reefer-in-refrigeration] to better understand these specialized units that keep perishable goods safe…
Click Media Reveals Strategic Insights SEO's Role in Driving Business Growth Unv …
SEO is a strategy for enhancing a website's exposure in search results by utilizing relevant keywords. Marketers and content writers can improve website rankings by leveraging phrases that people regularly search for. This method works for a variety of search engines.
SEO is fundamentally distinct from other types of marketing, but it is critical to a comprehensive digital strategy. Let's see how the Best SEO Services [https://www.click.media] actually function.
The Function of…
More Releases for Bioparticles
CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Parti …
CD Bioparticles announces its advanced line of multiplex fluorescence particles.
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces its advanced line of multiplex fluorescence particles [https://www.cd-bioparticles.com/products/multiplex-assays-466.html] designed to streamline complex biological assays in flow cytometry experiments. These particles exhibit low signal widths in the forward scatter, side scatter and fluorescence channels. Various surface modifications, channels and sizes are also supported.
Flow cytometry is a convenient detection…
CD Bioparticles Introduces Functional Agarose Particles for Biomedical Research …
CD Bioparticles proudly announces the launch of its new Functional Agarose Particles.
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles proudly announces the launch of its new Functional Agarose Particles [https://www.cd-bioparticles.com/products/functional-agarose-particles-1065.html] designed for a variety of applications in the field of bioconjugation, isolation, and purification of biomacromolecules. These particles are ideal for researchers working in areas such as protein purification, antibody production, and nucleic acid isolation.
CD…
CD Bioparticles Announces Offering of Polystyrene Family Polymers for Drug Deliv …
CD Bioparticles announces the availability of Polystyrene Family polymers for a variety of drug delivery applications.
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is pleased to announce the availability of Polystyrene Family polymers [https://www.cd-bioparticles.net/polystyrene-family] for a variety of drug delivery applications. These polymers offer tunable physicochemical properties that enable sustained release profiles and improved drug bioavailability.
The polystyrene family, a group of polymers derived from…
CD Bioparticles Introduces New Polyolefin Family Polymers for Drug Delivery Appl …
CD Bioparticles announces Polyolefin Family polymers for a variety of drug delivery applications.
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has recently expanded its low PDI polymer portfolio and announces its new offering of Polyolefin Family [https://www.cd-bioparticles.net/polyolefin-family] polymers with a wide range of properties that make them well-suited for a variety of drug delivery applications.
Low dispersion index polymers are polymeric compounds with low molecular…
CD Bioparticles Introduces the Launch of Organic Gold Nanoparticles
With years of experience in the pharmaceutical and life science sector, CD Bioparticles now launches a comprehensive list of organic gold nanoparticles for research applications. These organic gold nanoparticles have a hydrophobic surface character and have great solubility in a wide range of organic solvents.
CD Bioparticles offers a comprehensive list of coatings, functional and conjugated gold nanoparticles through precise surface engineering. It offers gold nanoparticles functionalized with reactive groups such…
CD Bioparticles Expands Its Biodegradable Polymers Portfolio with Dendrimers
As a leading manufacturer and supplier of various drug delivery products and services, CD Bioparticles recently introduces a series of dendrimers for research use, such as DMPA-G1-TMP-Acetylene, DMPA-G1-TMP-Azide, DMPA-G1-TMP-Carboxyl, and DMPA-G1-TMP-NHBOC. These biodegradable polymers can be used in theranostics, biosensors, optics, adhesives and coatings.
With customized delivery strategies, precise designs and modifications of drugs or drug-contained cargos, and advanced technical platforms, CD Bioparticles can help scientists to solve problems in the…
